Prof. Shuang Li 李双
Chief Physician, Professor
Department of Gynecologic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Evaluation and treatment of persistent HPV infection, lower genital tract precancerous lesions, and early invasive cancer. Expertise in colposcopy, LEEP, and laser therapy for cervical, vaginal, and vulvar conditions.
Dr. Li holds a medical doctorate and completed postdoctoral training in the US. A professor and chief physician with nearly 30 years of experience, Dr. Li leads the Cervical Disease Specialty at Tongji Hospital. Training includes ASCCP certification in cytopathology and colposcopy. Research focuses on clinical translational medicine for cervical cancer, including the identification of genetic susceptibility loci in Han Chinese women.
Professional roles
- Vice Chair, Colposcopy and Cervical Disease Committee, Obstetrics and Gynecology Branch, Chinese Medical Doctor Association (CCNC)
- Standing Committee Member, Chinese Society of Colposcopy and Cervical Pathology (CSCCP)
- Standing Committee Member, Cervical Disease and Cytopathology College, Chinese Academy of Obstetrics and Gynecology
- Standing Committee Member, Cervical Disease Branch, China Medicine Education Association
Name order: in Chinese the family name comes first (Li Shuang). Papers usually list the name as Shuang Li or Li S.
Selected publications
63 papers on PubMed matched by name and affiliation; 12 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int J Mol Sci, 2026 (senior author): Basic Clinical Bidirectional Empowerment: Synergistic Breakthrough in Molecular Mechanisms and Clinical Management of Small Cell Cervical Carcinoma. PubMed 42589439
- Int J Mol Sci, 2025 (senior author): From Viral Infection to Genome Reshaping: The Triggering Role of HPV Integration in Cervical Cancer. PubMed 41009776
- J Educ Health Promot, 2025 (senior author): Impact of professionalism education integrated with mini-CEX on clinical competency in obstetrics and gynecology clerkships: A brief report. PubMed 40979343
- Front Immunol, 2025 (senior author): Lysine methyltransferase 2D deficiency drives complete response to pembrolizumab in PD-L1-High cholangiocarcinoma: a case report and review of literature. PubMed 40895533
- Front Med (Lausanne), 2024 (senior author): A multi-variable predictive warning model for cervical cancer using clinical and SNPs data. PubMed 38455474
- BMC Med, 2022 (senior author): Sequential gene expression analysis of cervical malignant transformation identifies RFC4 as a novel diagnostic and prognostic biomarker. PubMed 36352434
- J Cancer, 2021 (senior author): 6 Circulating miRNAs can be used as Non-invasive Biomarkers for the Detection of Cervical Lesions. PubMed 34335927
- Biomed Res Int, 2020 (senior author): GJA1 Expression and Its Prognostic Value in Cervical Cancer. PubMed 33299882
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion